Recherche
-
Saffron extract interferes with lipopolysaccharide-induced brain activation of the kynurenine pathway and impairment of monoamine neurotransmission in mice
(Frontiers in Nutrition. vol. 10, pp. 1-15, 2023-10-05)Article de revueLibre accès -
Role of daily feeding rhythms in the genetics of feed efficiency in growing pigs
Communication dans un congrès -
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort
(European Neuropsychopharmacology. vol. 77, pp. 67-79, 2023-12-01)Article de revueLibre accès -
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia
Document de travail - Pré-publicationLibre accès -
Physical and mental health status of former smokers and non-smokers patients with bipolar disorder
(Acta Psychiatrica Scandinavica. vol. 147, n° 4, pp. 373-388, 2023-02-07)Article de revueLibre accès -
Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder
(Brain, Behavior, and Immunity. vol. 111, pp. 61-75, 2023-07-01)Article de revueLibre accès -
Acute Effect of a Saffron Extract (Safr'Inside) and Its Main Volatile Compound on the Stress Response in Healthy Young Men: A Randomized, Double Blind, Placebo-Controlled, Crossover Study.
(Nutrients. vol. 15, n° 13, 2023-06-27)Article de revueLibre accès -
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
(Translational Psychiatry. vol. 13, n° 1, pp. 341, 2023-11-07)Article de revueLibre accès -
Effects of a polyphenol-rich grape and blueberry extract (Memophenol™) on cognitive function in older adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.
(Frontiers in Psychology. vol. 14, pp. 1144231, 2023-01-01)Article de revueLibre accès -
Subjects suffering from bipolar disorder taking lithium are less likely to report physical pain: a FACE-BD study
(European Psychiatry. pp. 1-16, 2023-12)Article de revueLibre accès